1
↑0
↓1
—0
Evidence suggests Melatonin maydecreaseDiabetes.
2 studies (1 claims)
Exact normalized-entity scope. Exact scope. Claims must match the selected normalized intervention and endpoint IDs; signal links are not expanded. Direction describes the stored endpoint phrase and is not a benefit/harm judgement.
2 of 2
| Intervention | Direction | Endpoint | Type | Population | Dosage | Title |
|---|---|---|---|---|---|---|
| melatonin | No effect - seems to be well funded | diabetes | Human | — | Not specified | Clinical uses of melatonin: evaluation of human trials.cited 219× |
| melatonin | Decreases - has an antidiabetic effect | diabetes | Molecular | several animal models | Pharmacological doses mentioned (specific amounts not provided). | Melatonin in energy control: Circadian time-giver and homeostatic monitor.cited 7× |